Healius Limited · ASX:HLS
Healius — Shareholder Meeting (November 2019)
20 slides from Healius's shareholder meeting presentation, Nov 25, 2019
Slide 1: 2019 Annual General Meeting
2019 Annual General Meeting 25 November 2019
Slide 2: Robert Hubbard, Chairman
Robert Hubbard Chairman 2 2019 Annual General Meeting
Slide 3: Board of Directors
Board of Directors Robert Hubbard Arlene Tansey Dr Paul Jones Dr Malcolm Parmenter Non-executive Chairman Non-executive Director Non-executive Director MD & CEO Charles Tilley Sally Evans Gordon Davis Company Secretary Non-executive Director Non-executive Director 3 2019 Annual General Meeting
Slide 4: Executive Leadership Team
Executive Leadership Team Malcolm Parmenter John McKechnie Scott Beattie Dean Lewsam MD & CEO Chief Executive, Pathology Chief Executive, Chief Executive, Imaging Medical Centres Ben Korst Maxine Jaquet Janet Payne Peter Wilson Chief Executive, Chief Financial Officer Group Executive, Group Executiv
Slide 5: A year in review
A year in review • ‘Healius’ brand rolled out • Acquired Montserrat Day Hospitals • Strategic initiatives progressed • Political engagement • Organisational re-design • Sustainability reporting 5 2019 Annual General Meeting
Slide 6: Financial results
Financial results Underlying FY 2019 Pathology Medical Centres1 Imaging Corporate Group2 $m Revenue 1,128.3 327.4 391.3 0.3 1,804.5 EBITDA 136.2 61.4 54.1 (15.7) 236.0 EBIT 111.1 37.6 38.7 (20.1) 167.3 UNPAT 93.2 FY 2018 Pathology Medical Centres1 Imaging Corporate Group2 $m Revenue 1,090.6 289.7 36
Slide 7: Strategic projects
Strategic projects FY 2019 Laboratory Leapfrog iCAR Corporate $m Platforms Total Opex (adjusted between reported and underlying) 10.3 13.1 3.1 9.2 Total Capex 4.2 31.6 5.0 0.0 Total Project Costs 14.5 44.7 8.1 9.2 • Four key projects which are transformational in nature and unlikely to be undertaken
Slide 8: Cash flow and capital
Cash flow and capital • Growth capex $176m - partly funded by the capital raise • Including Montserrat Day Hospitals acquisition • Net debt $678m • Bank gearing ratio 2.4x • Dividends o Final 3.4 cents per share o Total 7.2 cents per share 8 2019 Annual General Meeting
Slide 9: Dr Malcolm Parmenter, Managing Director & CEO
Dr Malcolm Parmenter Managing Director & CEO 9 2019 Annual General Meeting
Slide 10: Executive Leadership Team
Executive Leadership Team Malcolm Parmenter John McKechnie Scott Beattie Dean Lewsam MD & CEO Chief Executive, Pathology Chief Executive, Chief Executive, Imaging Medical Centres Ben Korst Maxine Jaquet Janet Payne Peter Wilson Chief Executive, Chief Financial Officer Group Executive, Group Executiv
Slide 11: Healius brand
Healius brand 11 2019 Annual General Meeting
Slide 12: Pathology
Pathology • Creditable performance with strong 2H returns • Upgraded Serum Work Area in NSW in October SWA Benefits: o increased automation o test costs and turnaround times reduced o leading-edge clinical methodology o capacity for growth • Progress on implementing new Laboratory Information System
Slide 13: Medical Centres
Medical Centres • Record GP cohort of 1,164 • Leapfrog investment: o Practice management system (MedicalDirector 3) rolled out New consumer services o Appointment capability introduced o New consumer services o 15 centres transformed and extended Maroubra centre refurbishment under Leapfrog 13 2019
Slide 14: Medical Centres (cont.) - Join-the-queue remotely
Medical Centres (cont.) Join-the-queue remotely • Patients can join the queue from anywhere – reducing time spent in waiting room • Patients receive an SMS alert 60 and 30 minutes prior, advising them to head to the centre • Currently available at 7 centres “It was so convenient to be able to join t
Slide 15: Medical Centres (cont.) - Start-up businesses
Medical Centres (cont.) Start-up businesses Dental • Success in growth of Dental • Launch SwiftQ Dental • Affordable dental care – 6 services at $99 each IVF • Success in growth of Adora Fertility • New clinic opened in WA and new satellite clinics in QLD & NSW • Expansion of Sydney and Melbourne cl
Slide 16: Montserrat
Montserrat • Acquired October 2018 • 3 hospitals opened including Westside with 40+ specialists • Building diversified platform for future growth: o In US strong shift to day procedures where ASCs grown to > 5,000 o In Australia, similar cost drivers and technology innovation • Expected strong growt
Slide 17: Imaging
Imaging • Third consecutive year of double-digit growth “Thank you, the new tele-connect (iCAR) system is a really big improvement, and has • Successful contract wins and delivery: made a massive difference to my work” Radiographer quote o Northern Beaches Hospital o Australian Defence Force Health
Slide 18: Organisational re-design
Organisational re-design • Simplify and streamline management of the portfolio • Improve agility and autonomy of the businesses o Devolved support functions o Leaner Head Office • Profitability improvement initiatives: o Roles, functions and management layers o Procurement activities o Property port
Slide 19: Outlook
Outlook • Long-term drivers remain positive • Well-funded frontline health system key to efficient and effective healthcare • Indexation July 2019 in General Practice and July 2020 in Imaging • Recruitment in General Practice remains competitive FY 2020 forecast • Expect underlying FY 2020 NPAT to b
Slide 20: tihealius
tihealius